BRIEFING

 Guaifenesin, Pseudoephedrine Hydrochloride, and Dextromethorphan Hydrobromide Capsules. This proposal is based on the version of the monograph official prior to 2013. It is proposed to omit this monograph for the following reasons:

1. No drug products formulated as defined under Guaifenesin, Pseudoephedrine Hydrochloride, and Dextromethorphan Hydrobromide Capsules are currently marketed in the United States.

2. The drug product is currently not on the list for approved veterinary medicine in the United States.

 (SM2: L. Ahmad)

 Case ID—SUB-1204